Patient Empowerment With the Patient Perspective

Colorectal Cancer Clinical Trial

— PEPP  

Official title:

PEPP - Patient Empowerment With the Patient Perspective

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03654950
• Other study ID #: PEPP
• Status: Completed
• Start date: June 1, 2018
• Est. completion date: December 1, 2021

Study information

• Verified date: November 2022
• Source: Sahlgrenska University Hospital, Sweden
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The overall aim with this study is to gain a deeper understanding of patient perceptions regarding empowerment in relation to a health platform.

Description:

This is a two-stage study design. The first stage consists of focus groups interviews. Three focus groups with 6-8 patients (colorectal cancer patients diagnosed at least one year ago) in each group, will be invited. The focus group interviews will be moderated by one researcher, but accompanied with a second observing researcher. The participants will be identified using the regional Swedish ColoRectal Cancer Registry in Västra Götaland. The participants will be contacted by a short letter (appendix) indicating that we will call them with more information. The participants will by phone be asked to participate in the study and then invited to the focus groups. The second phase of the project includes a questionnaire, which will be sent to 200 patients from the same population. The questionnaires will be delivered by using the Sunet Survey system, which is a system approved by University of Gothenburg. If the participants prefers a paper copy, or lack the possibility to reply online, a paper copy will be send via mail instead. At this moment the investigators have developed a questionnaire, which may be refined due to the understating achieved from the focus group interviews.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: December 1, 2021
• Est. primary completion date: November 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient with colorectal cancer

Exclusion Criteria:

• Inability to give informed consent or speaking and reading the Swedish language.

Related Conditions & MeSH terms

• Colorectal Cancer
• Colorectal Neoplasms

Intervention

Other:
• No intervention
Interviews and questionnaires

Locations

Country	Name	City	State
Sweden	Dept. of Surgery, Sahlgrenska University Hospital/Ostra	Gothenburg

Sponsors (2)

Lead Sponsor	Collaborator
Sahlgrenska University Hospital, Sweden	Högskolan Väst

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient reported experiences in themes	interview	1 day
Secondary	Patient reported experiences divided into themes	Interview	12 months